WallStreetZenWallStreetZen

AnalystsYanan Zhu
Yanan Zhu's Stock Forecasts

Analyst Ranking
Bottom 5%
#3992 out of 4174 analysts
Average Return
-12.9%
Win Rate
53%9 out of 17
Risk vs Reward
Poor
Good

Yanan Zhu's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Global Blood Therapeutics IncGBT
+34.71%$23.05$31.05
2016-09-30 -
2017-09-29
Buy
Global Blood Therapeutics IncGBT
+32.26%$47.15$62.36
2019-10-09 -
2020-10-09
Buy
Rapt Therapeutics IncRAPT
+28.08%$21.90$28.05
2023-01-04 -
2023-02-03
Strong Buy
Avidity Biosciences IncRNA
+22.69%$19.70$24.17
2023-01-04 -
2023-02-03
Strong Buy
Editas Medicine IncEDIT
+21.86%$9.24$11.26
2023-01-04 -
2023-02-03
Strong Buy

Yanan Zhu Analyst Color

Get additional color on Yanan Zhu's coverage of popular stocks

Yanan Zhu's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Taysha Gene Therapies IncTSHA
2Strong Buy$10.00+726.45%Maintains
a month ago
Sangamo Therapeutics IncSGMO
2Strong Buy$15.00+327.35%Maintains
a month ago
Rapt Therapeutics IncRAPT
2Strong Buy$48.00+71.12%Maintains
a month ago
Intellia Therapeutics IncNTLA
1Strong Buy$120.00+177.59%Maintains
a month ago
Editas Medicine IncEDIT
3Strong Buy$36.00+219.72%Maintains
a month ago
Avidity Biosciences IncRNA
1Strong Buy$55.00+127.55%Maintains
a month ago
Adaptimmune Therapeutics PLCADAP
1Hold$3.00+80.72%Maintains
3 months ago
Aeglea Biotherapeutics IncAGLE
2Strong Buy$2.00+296.83%Upgrades
3 months ago
Applied Genetic Technologies CorpAGTC
2Hold$0.40+1.52%Maintains
3 months ago
Uniqure NvQURE
1Hold$24.00+6.57%Maintains
6 months ago
Bluebird Bio IncBLUE
2Hold$8.00+20.30%Maintains
a year ago
Beam Therapeutics IncBEAM
1Strong Buy$145.00N/AInitiates Coverage On
2 years ago
Argenx SeARGX
1Hold$326.00N/AMaintains
2 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$52.50N/ADowngrades
2 years ago
Chemocentryx IncCCXI
1Strong Buy$79.00N/AInitiates Coverage On
3 years ago
Global Blood Therapeutics IncGBT
4Strong Buy$133.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.